Center for Continuing Medical Education's help center webpage.
 
CME Passport website.
 
2026 Tutorial on Neoplastic Hematopathology: Focus on New Classifications
 
11th Annual Updates from ASH 2025: Practice-Changing Abstracts
 
University of Chicago Pancreas Symposium: Pancreatic Cysts and Cancer
 
Organ Preservation and Survival in Head and Neck Cancer webpage.
 
3rd Annual University of Chicago Multidisciplinary Breast Cancer Symposium webpage.
 
 
3rd Annual University of Chicago Stroke Symposium
 
3rd Annual University of Chicago Practice Updates in Hematology and Oncology
 

Welcome

We are excited about sharing the latest clinical and research findings through Continuing Medical Education. You will hear about the most recent clinical advances happening here and in other leading institutions around the world. Our CME activities highlight innovative procedures and technologies, examine current controversies in treatment, and provide updates on the latest advances in the understanding and treatment of disease.

 

Help CenterCME NewsIllinois CME Requirements    AI in Medicine

Upcoming Courses

  • e-Learning
Practice Solutions for Addressing Treatment Delays in Black Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
e-Learning The growing number of therapeutic options for prostate cancer creates challenges for navigating optimal treatment selection and sequencing. In response, this educational activity has compiled education and practical tools to initiate meaningful conversations and improve interprofessional care.
  • e-Learning
Should I Treat This Patient With Geographic Atrophy? Weighing Benefits and Burden of Treatment With Complement Inhibitors
Online Clinical Commentary This point-counterpoint digital activity uses case-based discussions to frame differing perspectives around complex clinical questions, helping learners critically review the risk-benefit profiles of novel agents and optimally select GA patients who may qualify for treatment.
  • e-Learning
Systems-Based Solutions for Addressing Treatment Delays in Black Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
e-Learning This activity aims to ensure that you and your practice can achieve measurable changes to optimize your infrastructure and processes to support treatment, therapy selection, and care coordination for diverse patients with metastatic castration-resistant prostate cancer (mCRPC).

Pages

Accreditation

ACCME AccreditationThe University of Chicago Pritzker School of Medicine has Accreditation with Commendation status by the Accreditation Council for Continuing Medical Education (ACCME) through November 30, 2029.
 
Learn more about Accreditation with Commendation by the ACCME.